 |  | · Established Young Dong Medical Co., Ltd
(Obtained license for wholesale of medical supplies)
· Contracted agency agreement with Abbott Korea
|
 |  | · Obtained KGSP certification |
 | | · CEO Lee Jin-Woo inauguration |
 |  | · Technology transfer agreement with Inha University Academic-Industrial
Collaboration Team |
 | · Established 'YD Global Life Science R&D center' |
 | · Founded YD Global Life Science Co.,Ltd.(capital KRW 500 million) |
 |  | · Certified as Venture Enterprise by Korea Technology Finance Corporation |
 | · Patent application of the composition for prevention or treatment for pancreatitis, containing active constituent of Phellodendron Amurense Bark Extract |
| · Patent application of the composition for prevention or treatment for arthritis, containing active constituent of mixed extracts from omija, scutellaria, kalopanax |
 | | · Signed MOU for botanical drug of omija with the city of Mungyeung |
 | · Start development of antianxiety drug |
 | · Body application test of omija extract functional food for the improvement of arthritis and cartilage |
 | | · Patent registration of the composition for prevention or treatment for arthritis, containing active constituent of mixed extracts from omija, scutellaria, kalopanax |
 | · Signed MOU of joint development and investment with Kyung Dong Pharmaceutical Corp.
· Perform government-funded project of SMBA's R&D Program for Small and Medium-sized Enterprises
(Development for commercialization of omija extract health functional food of antiobesity) |
 | | · Signed MOU for joint development with Botanical drug research center of Hallym University |
| · Signed MOU for joint development with Hanhwa Pharmacy Co., Ltd. and Hawon Pham Co., Ltd.
· Start development of neuropathy pain treatment |
| · Completed pre-clinical test of antianxiety |
| · Patent registration of the composition for nerve tranquilization and for prevention and treatment of cranial nerve related anxiety, containing active constituent of compounds separated from Chrysanthemum flower extract |
 | | · Patent application of manufacturing process of penta-heterocyclic derivatives, and of pharmaceutical composition containing penta-heterocyclic derivatives |
 | · Contracted Exclusive Agreement with Synergy Health PLC, world No. 1 UK company in the field of decontamination and sterilization
· Patent application of the composition for prevention or treatment for degenerative cerebropathy, containing active constituent of salicaceous plant extract |
| · Neuropathy Pain Treatment selected as KDDF |
| · Exclusive Distributorship Agreement with Medora Snacks LLC. USA(Wellness Division) |
| · Patent registration of the composition for prevention or treatment for pancreatitis, containing active constituent of Phellodendron Amurense Bark Extract |
| · Merged with Young Dong Medical Co., Ltd. |
 | | · Moved headoffice and R&D center to Intellectual Industry Center at Seongnam Techno Valley |
| · Free-tasting event of Popcorners snack with Nonghyub at NH Yangjae and Chang-dong branch |
| · Technology transfer agreement of atopic dermatitis treatment with Seoul University Academic-Industrial
Collaboration Team |
| · 'Health functional food for reducing body fat utilizing pockmarked cabbage extract' - selected as R&D project by IPET |
 | · Neuropathy Pain Treatment re-selected as KDDF |
|
· Technology transfer agreement of diabetic neuropathy treatment with Ajou University Academic-Industrial Collaboration Team |
 | | · Exclusive Distributorship Agreement of medical device(IV Set) with Asia Medical, G-Medi Co., Ltd. |
